Holen Sie sich die Stockscreener-App
316.10
0.83%
3.3839
Schlusskurs vom Vortag:
$312.72
Offen:
$313.47
24-Stunden-Volumen:
242.34K
Relative Volume:
0.16
Marktkapitalisierung:
$45.58B
Einnahmen:
$2.50B
Nettoeinkommen (Verlust:
$-226.32M
KGV:
-192.61
EPS:
-1.6412
Netto-Cashflow:
$71.51M
1W Leistung:
+14.82%
1M Leistung:
+16.80%
6M Leistung:
+51.71%
1J Leistung:
+97.30%
1-Tages-Spanne:
$313.47
$321.72
1-Wochen-Bereich:
$263.55
$326.03
52-Wochen-Spanne:
$152.62
$326.03
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
316.18 | 45.08B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
600.92 | 223.70B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
205.72 | 145.83B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
571.36 | 46.22B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.85 | 42.22B | 7.23B | 1.41B | 1.09B | 4.979 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Eingeleitet | William Blair | Outperform |
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
NTRA Maintained by Guggenheim -- Price Target Raised to $360 - GuruFocus
Natera To Support New Clinical Trial Assessing Ctdna Dynamics With Latitud In Advanced Skin Cancers - TradingView
Natera partners with Kupando for phase 1 cancer trial in Germany - Investing.com
First Patient Dosed as Trial Tests Immunotherapy in Skin Cancers - Stock Titan
Technical Reactions to NTRA Trends in Macro Strategies - Stock Traders Daily
NTRA Q2 Deep Dive: Oncology Milestones and New Product Launches Drive Growth - finance.yahoo.com
What to Know About This Natera Insider Transaction as Shares Surge to Record Highs - fool.com
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests - fool.com
A Natera Insider's Shares Vested Before the Firm Reported Revenue Surged 38%. Here's How to Read It - fool.com
A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know - fool.com
Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know - finance.yahoo.com
Natera Preps for MRD Test Expansion, Entry Into Early Cancer Detection on Heels of Recent Catalysts - 360Dx
Natera Insider Sold Shares Worth $2,888,325, According to a Recent SEC Filing - marketscreener.com
Natera (NTRA) Is Up 20.3% After Raising 2026 Guidance And Expanding Signatera’s Oncology Reach - simplywall.st
Natera (NTRA) Is Up 20.3% After Shelf Filing And Higher 2026 Guidance Has The Bull Case Changed? - finance.yahoo.com
NATERA, INC. : BERNSTEIN RAISES TARGET PRICE TO $365 FROM $310 - webull.com
Key facts: Natera, Inc. Q2 revenue $752.8M; JP Morgan raises PT to $360 - TradingView
Natera (NTRA) Stock Reprices Higher As Signatera Scale Starts Showing Up - Sahm
Natera Q2 2026 slides: revenue up 38%, guidance raised $100M - Investing.com South Africa
Natera’s Matthew Rabinowitz sells $641,800 in shares - Investing.com
Natera, Inc. (NTRA) chair logs 2,000-share sale via 10b5-1 plan - Stock Titan
Is Natera Inc (NTRA) Overvalued After 21.4% Rally? GF Value Says - GuruFocus
Natera Q2 2026 slides: record volumes drive 38% revenue growth By Investing.com - Investing.com Nigeria
Natera (NTRA) insider Rabinowitz files Form 144 for 2,000-share sale - Stock Titan
Natera, Inc. Stock 12‑Month Price Target Raised to $317.33, Implies 20% Upside - TradingView
Natera Shares Soar To All-Time High Cementing Chairman As Billionaire - Forbes
Natera Stock Surges After Q2 Earnings Beat And Guidance Hike - StocksToTrade
Natera Stock Jumps After Q2 Beat And Guidance Hike - StocksToTrade
NTRA Surges As Natera Lifts 2026 Revenue Outlook - StocksToTrade
What To Know About This IBD 50 Stock's 'Blowout' Quarter - Investor's Business Daily
Natera, Doximity, PubMatic, Airbnb And Other Big Stocks Moving Higher On Friday - benzinga.com
NTRA Stock Soars After Earnings Beat And Raised 2026 Outlook - StocksToTrade
Natera CEO Says Company Is 'Clearly on a Roll' After Record Test Volumes, Raises Outlook - TradingView
Natera Up Over 19%, On Pace for Record High Close -- Data Talk - Moomoo
NTRA Stock Surges After Big Earnings Beat And Guidance Hike - StocksToTrade
Natera (NASDAQ: NTRA) holder Jonathan Sheena plans 18,000-share stock sale - Stock Titan
Natera stock hits all-time high at 310.0 USD - Investing.com
RBC Capital Adjusts Price Target on Natera to $350 From $275, Maintains Outperform Rating - marketscreener.com
Natera, Inc. Q2 2026 Earnings Call Summary - finance.yahoo.com
Natera, Inc. 2026: Revenue $752.75M, EPS ($0.47) — 10-Q Summary - TradingView
Loss per share narrows as Natera (Nasdaq: NTRA) grows Q2 revenue - Stock Titan
Form 4 Natera Inc For: 6 August By Investing.com - Investing.com South Africa
Natera Reports Strong Q2 2026 Performance and Record Growth in Oncology - Oncodaily
NATERA, INC. : TD COWEN RAISES TARGET PRICE TO $340 FROM $325 - Bitget
Natera Q2 2026 slides: revenue up 38%, guidance raised on MRD surge - Investing.com
Natera Q2 Earnings Call Highlights - finance.yahoo.com
Natera Inc (NTRA) (Q2 2026) Earnings Call Highlights: Record Volumes and Raised Guidance Signal ... - finance.yahoo.com
Natera Inc earnings beat by $0.02, revenue topped estimates - Investing.com
Natera Q2 2026 slides: record MRD volumes drive 38% revenue growth - Investing.com
Natera (NTRA) Reports Q2 Loss, Beats Revenue Estimates - finance.yahoo.com
Earnings call transcript: Natera tops revenue view in Q2 2026, shares jump after hours - Investing.com
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Natera Inc-Aktie (NTRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sheena Jonathan | CO-FOUNDER |
Aug 07 '26 |
Sale |
315.66 |
9,150 |
2,888,325 |
236,464 |
2.62%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):